Best Ideas 2018 features all the nominated entries submitted to the Youth Citizen Entrepreneurship Competition under ‘Submit your Idea’ category. All the entries consist of innovative solution or proposition for an enterprise that champions the Sustainable Development Goals. They can be on the conceptual, planning, or start-up stage. If you want to know the 10 finalists in this category, click HERE
Lediscan: a low-cost hand-held device to detect cervical cancer before it occurs
Explain your idea in details:
The World Health Organization recommends the use of the Visual Inspection with Acetic acid technique (VIA) for cervical cancer screening in developing countries. While VIA itself is cheap, it requires training a health care workforce and even with good training, there is human error associated with this approach leading to missed diagnoses and wrong diagnoses. Lediscan leverages the VIA technique and image processing/ recognition technology to rapidly detect precancerous stages of cervical cancer and other potentially cancerous lesions of the cervix with a high degree of accuracy and reproducibility. Thereby eliminating human error and improving the speed of the diagnostic process. Lediscan automates the process of diagnosing precancerous and suspicious cervical lesions. The current practice in most developing countries is to treat all positive patients on the spot (commonly using cryotherapy). The data from the device can potentially be linked with various cervical cancer mass-screening databases or programs and institutions that treat cervical cancer.
Expected impact of your idea on sustainable development
With Lediscan millions of women and young who do no have access to formal health care facilities can be screened for cervical cancer and subsequently treated. Cervical cancer is the 2nd leading cause of cancer-related death and this predominantly affects developing countries. Lediscan can curb the incidence of cervical cancer. While the immediate goal is for a device that can be used even by nonmedical personnel, the ultimate goal is to empower women with a self-administered screening test. A device that every woman can own in order to actively take responsibility for her own health.
Plans for implementation and sustainability
Presently, we have completed the hardware prototype and have a 3D printed model or the device. The next phase involves producing the samples/models that will be used to gather data that will be used to build the machine learning algorithm. The algorithm will then be incorporated into the device to provide a point of care diagnosis within seconds of administering the test. Those who test positive can receive treatment on the spot or be referred to the appropriate providers. Lediscan is ideal for rural areas, mass cervical screening programs conducted by governments and NGOs. It can serve as a stand-alone diagnostic technology. It can also serve as an add-on technology for larger corporations that work on chemoablation or thermoablation for the treatment of cervical cancer, thus making Lediscan an appeal target for acquisition by such companies or an implementation partner.
Obieze is an innovative Nigerian physician with a passion for addressing health inequities in Africa by promoting and providing access to health care and innovative solutions to the challenges of vulnerable populations. He is the founder of Joint Medical Lifesavers Foundation, a nonprofit organization that provides access to care for women and children in rural Nigeria. Dr. Obieze has a masters in global health sciences from the University of California San Francisco and has received numerous local and international awards for public service, health innovation, and research. These include the 1) University of California San Francisco Chancellor's award for public service 2015, 2) the D-prize social innovation award (2016), 3) State honors award for Community service from the Nigerian government (2012), 4) Productivity award (2012) 5) Panamerican Trauma society international research award etc.